Found: 6
Select item for more details and to access through your institution.
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 10, p. 775, doi. 10.1002/gcc.20900
- By:
- Publication type:
- Article
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 3371
- By:
- Publication type:
- Article
Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.861324
- By:
- Publication type:
- Article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 5, p. 2, doi. 10.1186/bcr3557
- By:
- Publication type:
- Article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145013
- By:
- Publication type:
- Article